Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of immune system physiology (HP:0010978)help
Parent Node:
expand
Opportunistic infection (HP:0031690)help
..Starting node
..expand
Severe viral infection (HP:0031691)help
Term ID: 31691
Name: Severe viral infection
Synonym:
Definition: An unusually severe viral infection.
Comments:
Reference: HP:0031691
Genes and Diseases:
 
       Child Nodes:
........expandSevere cytomegalovirus infection (HP:0031692) help
........expandSevere Epstein Barr virus infection (HP:0031693) help
........expandSevere adenovirus infection (HP:0031694) help
........expandSevere parainfluenza infection (HP:0031695) help

 Sister Nodes: 
..expandDisseminated cryptosporidium infection (HP:0031699) help
..expandDisseminated viral infection (HP:0031696) help
..expandInvasive parasitic infection (HP:0031700) help
..expandobsolete Disseminated Bacillus Calmette-Guerin infection (HP:0031698) help
..expandRecurrent opportunistic infections (HP:0005390) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0031691HP:0031691Severe viral infection0ADORA2A CL E G H135263ORPHA:363549Acute encephalopathy with biphasic seizures and late reduced diffusionHP:0040282 - Frequent1
HP:0031691HP:0031691Severe viral infection0BLM CL E G H6411058ORPHA:125Bloom syndrome314
HP:0031691HP:0031691Severe viral infection0CD27 CL E G H93911922OMIM:615122Lymphoproliferative syndrome 24
HP:0031691HP:0031691Severe viral infection0CD70 CL E G H97011937OMIM:618261LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3
HP:0031691HP:0031691Severe viral infection0CTPS1 CL E G H15032519OMIM:615897IMMUNODEFICIENCY 24; IMD242
HP:0031691HP:0031691Severe viral infection0DEF6 CL E G H506192760OMIM:619573IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87
HP:0031691HP:0031691Severe viral infection0DNASE2 CL E G H17772960OMIM:619858
HP:0031691HP:0031691Severe viral infection0DOCK2 CL E G H17942988OMIM:616433Immunodeficiency 406
HP:0031691HP:0031691Severe viral infection0FCGR3A CL E G H22143619OMIM:615707Immunodeficiency 204
HP:0031691HP:0031691Severe viral infection0IKBKG CL E G H85175961OMIM:300291ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1; EDAID152
HP:0031691HP:0031691Severe viral infection0IL2RA CL E G H35596008OMIM:606367IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD4165
HP:0031691HP:0031691Severe viral infection0IL2RB CL E G H35606009OMIM:618495Immunodeficiency 63 with lymphoproliferation and autoimmunity
HP:0031691HP:0031691Severe viral infection0IRF7 CL E G H36656122OMIM:616345Immunodeficiency 392
HP:0031691HP:0031691Severe viral infection0LAT CL E G H2704018874OMIM:617514Immunodeficiency 522
HP:0031691HP:0031691Severe viral infection0MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0031691HP:0031691Severe viral infection0MCM10 CL E G H5538818043OMIM:619313IMMUNODEFICIENCY 80 WITH OR WITHOUT CONGENITAL CARDIOMYOPATHY; IMD80
HP:0031691HP:0031691Severe viral infection0PGM3 CL E G H52388907OMIM:615816Immunodeficiency 2315
HP:0031691HP:0031691Severe viral infection0PIK3R1 CL E G H52958979OMIM:616005Immunodeficiency 3643
HP:0031691HP:0031691Severe viral infection0RAC2 CL E G H58809802OMIM:618986IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA; IMD73B9
HP:0031691HP:0031691Severe viral infection0REL CL E G H59669954OMIM:619652IMMUNODEFICIENCY 92; IMD921
HP:0031691HP:0031691Severe viral infection0SASH3 CL E G H5444015975OMIM:3010821
HP:0031691HP:0031691Severe viral infection0SH2D1A CL E G H406810820OMIM:308240Lymphoproliferative syndrome, X-linked, 137
HP:0031691HP:0031691Severe viral infection0STAT2 CL E G H677311363OMIM:616636Immunodeficiency 449
HP:0031691HP:0031691Severe viral infection0TGFB1 CL E G H704011766OMIM:618213INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE13
HP:0031691HP:0031691Severe viral infection0TLR7 CL E G H5128415631OMIM:301051IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED; IMD74
HP:0031691HP:0031691Severe viral infection0TPP2 CL E G H717412016OMIM:619220IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78
HP:0031691HP:0031691Severe viral infection0XIAP CL E G H331592OMIM:308240Lymphoproliferative syndrome, X-linked, 181
HP:0031691HP:0031691Severe viral infection0ZNFX1 CL E G H5716929271OMIM:619644IMMUNODEFICIENCY 91 AND HYPERINFLAMMATION; IMD91
HP:0031691HP:0031695Severe parainfluenza infection1 CL E G H
HP:0031691HP:0031694Severe adenovirus infection1 CL E G H
HP:0031691HP:0032170Severe varicella zoster infection1BLM CL E G H6411058ORPHA:125Bloom syndromeHP:0040283 - Occasional314
HP:0031691HP:0032170Severe varicella zoster infection1CD27 CL E G H93911922OMIM:615122Lymphoproliferative syndrome 24
HP:0031691HP:0033508EBV meningitis1CD27 CL E G H93911922OMIM:615122Lymphoproliferative syndrome 24
HP:0031691HP:0032170Severe varicella zoster infection1CD70 CL E G H97011937OMIM:618261LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3
HP:0031691HP:0032170Severe varicella zoster infection1CTPS1 CL E G H15032519OMIM:615897IMMUNODEFICIENCY 24; IMD242
HP:0031691HP:0031692Severe cytomegalovirus infection1DEF6 CL E G H506192760OMIM:619573IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87
HP:0031691HP:0031693Severe Epstein Barr virus infection1DNASE2 CL E G H17772960OMIM:619858
HP:0031691HP:0032170Severe varicella zoster infection1DOCK2 CL E G H17942988OMIM:616433Immunodeficiency 406
HP:0031691HP:0032170Severe varicella zoster infection1FCGR3A CL E G H22143619OMIM:615707Immunodeficiency 204
HP:0031691HP:0031692Severe cytomegalovirus infection1IKBKG CL E G H85175961OMIM:300291ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1; EDAID152
HP:0031691HP:0032170Severe varicella zoster infection1IL2RA CL E G H35596008OMIM:606367IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD4165
HP:0031691HP:0031692Severe cytomegalovirus infection1IL2RB CL E G H35606009OMIM:618495Immunodeficiency 63 with lymphoproliferation and autoimmunity
HP:0031691HP:0034249Severe influenza infection1IRF7 CL E G H36656122OMIM:616345Immunodeficiency 392
HP:0031691HP:0031692Severe cytomegalovirus infection1LAT CL E G H2704018874OMIM:617514Immunodeficiency 522
HP:0031691HP:0032170Severe varicella zoster infection1MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0031691HP:0031692Severe cytomegalovirus infection1MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0031691HP:0031692Severe cytomegalovirus infection1MCM10 CL E G H5538818043OMIM:619313IMMUNODEFICIENCY 80 WITH OR WITHOUT CONGENITAL CARDIOMYOPATHY; IMD80
HP:0031691HP:0032170Severe varicella zoster infection1PGM3 CL E G H52388907OMIM:615816Immunodeficiency 2315
HP:0031691HP:0031692Severe cytomegalovirus infection1PIK3R1 CL E G H52958979OMIM:616005Immunodeficiency 3643
HP:0031691HP:0032170Severe varicella zoster infection1RAC2 CL E G H58809802OMIM:618986IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA; IMD73B9
HP:0031691HP:0031692Severe cytomegalovirus infection1REL CL E G H59669954OMIM:619652IMMUNODEFICIENCY 92; IMD921
HP:0031691HP:0034249Severe influenza infection1SASH3 CL E G H5444015975OMIM:3010821
HP:0031691HP:0032170Severe varicella zoster infection1SASH3 CL E G H5444015975OMIM:3010821
HP:0031691HP:0031693Severe Epstein Barr virus infection1SH2D1A CL E G H406810820OMIM:308240Lymphoproliferative syndrome, X-linked, 137
HP:0031691HP:0032170Severe varicella zoster infection1TGFB1 CL E G H704011766OMIM:618213INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE13
HP:0031691HP:0033141Severe SARS-CoV-2 infection1TLR7 CL E G H5128415631OMIM:301051IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED; IMD74
HP:0031691HP:0031692Severe cytomegalovirus infection1TPP2 CL E G H717412016OMIM:619220IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78
HP:0031691HP:0031693Severe Epstein Barr virus infection1XIAP CL E G H331592OMIM:308240Lymphoproliferative syndrome, X-linked, 181
HP:0031691HP:0033431Cytomegalovirus colitis2 CL E G H
HP:0031691HP:0032247Persistent CMV viremia2IL2RB CL E G H35606009OMIM:618495Immunodeficiency 63 with lymphoproliferation and autoimmunity
HP:0031691HP:0032247Persistent CMV viremia2LAT CL E G H2704018874OMIM:617514Immunodeficiency 522
HP:0031691HP:0032247Persistent CMV viremia2MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0031691HP:0032247Persistent CMV viremia2PIK3R1 CL E G H52958979OMIM:616005Immunodeficiency 3643
HP:0031691HP:0032247Persistent CMV viremia2REL CL E G H59669954OMIM:619652IMMUNODEFICIENCY 92; IMD921
HP:0031691HP:0032247Persistent CMV viremia2TPP2 CL E G H717412016OMIM:619220IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78


Genes (28) :ADORA2A BLM CD27 CD70 CTPS1 DEF6 DNASE2 DOCK2 FCGR3A IKBKG IL2RA IL2RB IRF7 LAT MAGT1 MCM10 PGM3 PIK3R1 RAC2 REL SASH3 SH2D1A STAT2 TGFB1 TLR7 TPP2 XIAP ZNFX1

Diseases (27) :ORPHA:363549 ORPHA:125 OMIM:615122 OMIM:618261 OMIM:615897 OMIM:619573 OMIM:619858 OMIM:616433 OMIM:615707 OMIM:300291 OMIM:606367 OMIM:618495 OMIM:616345 OMIM:617514 OMIM:300853 OMIM:619313 OMIM:615816 OMIM:616005 OMIM:618986 OMIM:619652 OMIM:301082 OMIM:308240 OMIM:616636 OMIM:618213 OMIM:301051 OMIM:619220 OMIM:619644
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.